CBMC Financials 07/15/2014 19:21:19 Calypte Biome

CBMC Financials 07/15/2014 19:21:19
Calypte Biomedical Corp.
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 230 579 444
Cost of Revenue 216 417 260
Gross Profit 14 162 184
Operating Expenses
Research and Development 259 296 282
Sales, General and Admin. 710 839 999
Non-Recurring Items - - -
Other - - -
Operating Income (955) (973) (1,097)
Income From Continuing Operations
Add'l Income/Expense Items 1 223 10,931
Earnings Before Interest and Tax (954) (750) 9,834
Interest Expense 122 121 545
Earnings Before Tax (1,076) (871) 9,289
Income Tax - (178) 181
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (1,076) (693) 9,108
Non Recurring Events
Discontinued Operations - - (267)
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (1,076) (693) 8,841
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (1,076) (693) 8,841